Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024;19(14):1227-1229.
doi: 10.2217/nnm-2024-0098. Epub 2024 May 29.

Phytonanomedicine as a therapeutic regulator of the tumor microenvironment for inhibiting cancer metastasis

Sonali Sahoo  1   2 , Sanjeeb Kumar Sahoo  1
Affiliations
Editorial

Phytonanomedicine as a therapeutic regulator of the tumor microenvironment for inhibiting cancer metastasis

Sonali Sahoo et al. Nanomedicine (Lond). 2024.
No abstract available

Keywords: chemotherapy; metastasis; nanomedicine; phytochemicals; tumor microenvironment.

Plain language summary

“The development of phytonanomedicine-based approach seems to be a very promising candidate for modulating protumorigenic tumor microenvironment to suppress cancer metastasis.”.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

References

    1. Gerstberger S, Jiang Q, Ganesh K. Metastasis. Cell. 2023;186(8):1564–1579. doi:10.1016/j.cell.2023.03.003. - DOI - PMC - PubMed
    1. Ko AH. Clinical management: metastatic disease. Cancer J. (Sudbury, Mass). 2017;23(6):355–361. doi:10.1097/ppo.0000000000000294. - DOI - PubMed
    1. Neophytou CM, Panagi M, Stylianopoulos T, et al. . The role of tumor microenvironment in cancer metastasis: molecular mechanisms and therapeutic opportunities. Cancers. 2021;13(9):2053. doi:10.3390/cancers13092053. - DOI - PMC - PubMed
    1. Ganesh K, Massagué J. Targeting metastatic cancer. Nat. Med. 2021;27(1):34–44. doi:10.1038/s41591-020-01195-4. - DOI - PMC - PubMed
    1. Kartikasari AER, Huertas CS, Mitchell A, et al. . . Tumor-induced inflammatory cytokines and the emerging diagnostic devices for cancer detection and prognosis. Front. Oncol. 2021;11:692142. doi:10.3389/fonc.2021.692142. - DOI - PMC - PubMed

Publication types

LinkOut - more resources